<DOC>
	<DOCNO>NCT01922271</DOCNO>
	<brief_summary>The purpose study figure difference glycopyrronium bromide compare tiotropium early bronchodilation measure comprehensive assessment lung function include hyperinflation specific airway resistance patient moderate severe COPD .</brief_summary>
	<brief_title>Efficacy NVA237 Compared Tiotropium Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Male female adult age ≥40 year Patients moderate severe COPD define postbronchodilator Forced Expiratory Volume One Second ( FEV1 ) / ( FVC ) Forced Vital Capacity ratio &lt; 0.70 postbronchodilator FEV1 ≤70 % FEV1 ≥ 30 % predict normal value . Current exsmokers smoke history least 10 pack year . Pregnant nursing ( lactate ) woman Patients clinically significant laboratory abnormality runin Patients narrowangle glaucoma , symptomatic benign prostatic hyperplasia bladderneck obstruction moderate severe renal impairment ( GFR &lt; 50 ml/min/1,732 ) urinary retention . ( BPH patient stable treatment consider ) . Patients history asthma Patients pulmonary lobectomy lung volume reduction surgery lung transplantation Patients receive medication class list protocol prohibit . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>COPD</keyword>
</DOC>